http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019014700-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e61866e714198ee02a24037c9670828 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_592c0620383ef00ccb6e4eb9f2a246a8 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
filingDate | 2017-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d16d145c7dff069ae4631ee66f1913e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9101bd0a64f866dd9e8cd5aaeafe4229 |
publicationDate | 2019-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2019014700-A |
titleOfInvention | Ezetimibe-containing orally disintegrating tablet and method for producing the same |
abstract | An object of the present invention is to provide an ezetimibe-containing orally disintegrating tablet having excellent dissolution properties and orally disintegrating properties, and a method for producing the same. Ezetimibe particles having a d90 of 8.0 μm or less, 50.0% by weight or more of sugar alcohol and 0.0 to 0.1% by weight of sodium lauryl sulfate with respect to the total weight of the tablet, and An orally disintegrating tablet having a weight ratio of sugar alcohol to ezetimibe (sugar alcohol / ezetimibe) of 6.0 or more is provided. [Selection figure] None |
priorityDate | 2017-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.